Mermaid Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Liquidation

Mermaid Bio General Information

Description

Developer of intracellular antibodies and drugs intended to treat unmet patient needs. The company links single-domain antibodies (nanobodies) together with advancements in drug delivery (using mRNA/LNP systems) to create a proprietary platform capable of producing medicines, enabling the healthcare sector to develop particularly effective drugs.

Contact Information

Website
www.mermaid.bio
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Butenandtstraße 1
  • BioSysM Building
  • 81377 Munich
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Butenandtstraße 1
  • BioSysM Building
  • 81377 Munich
  • Germany

Mermaid Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mermaid Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 07-Apr-2025 Completed Bankruptcy: Liquidation
3. Early Stage VC 24-Apr-2023 Completed Product In Beta Test
2. Angel (individual) 13-Apr-2023 $300K $300K Completed Product In Beta Test
1. Grant 01-Jun-2022 $233K Completed Product In Beta Test
To view Mermaid Bio’s complete valuation and funding history, request access »

Mermaid Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of intracellular antibodies and drugs intended to treat unmet patient needs. The company links single-domain a
Drug Discovery
Munich, Germany
4 As of 2024

New Haven, CT
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mermaid Bio Competitors (3)

One of Mermaid Bio’s 3 competitors is Arvinas, a Formerly VC-backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arvinas Formerly VC-backed New Haven, CT
Genentech Formerly VC-backed South San Francisco, CA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
You’re viewing 3 of 3 competitors. Get the full list »

Mermaid Bio Patents

Mermaid Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024902175-A0 Chimeric binding molecules Pending 15-Jul-2024
WO-2024235910-A1 Nanobody for treating inflammation, autoinflammation or cancer Inactive 12-May-2023

Mermaid Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mermaid Bio FAQs

  • When was Mermaid Bio founded?

    Mermaid Bio was founded in 2022.

  • Where is Mermaid Bio headquartered?

    Mermaid Bio is headquartered in Munich, Germany.

  • What is the size of Mermaid Bio?

    Mermaid Bio has 4 total employees.

  • What industry is Mermaid Bio in?

    Mermaid Bio’s primary industry is Drug Discovery.

  • Is Mermaid Bio a private or public company?

    Mermaid Bio is a Private company.

  • What is Mermaid Bio’s current revenue?

    The current revenue for Mermaid Bio is .

  • How much funding has Mermaid Bio raised over time?

    Mermaid Bio has raised $847K.

  • Who are Mermaid Bio’s competitors?

    Arvinas, Genentech, and Alnylam Pharmaceuticals are competitors of Mermaid Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process